Nitric oxide inhibits the expression of AT1receptors in neurons
- 15 April 2012
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 302 (8), C1162-C1173
- https://doi.org/10.1152/ajpcell.00258.2011
Abstract
We have previously observed an increased of angiotensin II (ANG II) type 1 receptor (AT1R) with enhanced AT1R-mediated sympathetic outflow and concomitant downregulation of neuronal nitric oxide (NO) synthase (nNOS) with reduced NO-mediated inhibition from the paraventricular nucleus (PVN) in rats with heart failure. To test the hypothesis that NO exerts an inhibitory effect on AT1R expression in the PVN, we used primary cultured hypothalamic cells of neonatal rats and neuronal cell line NG108-15 as in vitro models. In hypothalamic primary culture, NO donor sodium nitroprusside (SNP) induced dose-dependent decreases in mRNA and protein of AT1R (10−5M SNP, AT1R protein was 10 ± 2% of control level) while NOS inhibitor NG-monomethyl-l-arginine (l-NMMA) induced dose-dependent increases in mRNA and protein levels of AT1R (10−5M l-NMMA, AT1R protein was 148 ± 8% of control level). Similar effects of SNP and l-NMMA on AT1R expression were also observed in NG108-15 cell line (10−6M SNP, AT1R protein was 30 ± 4% of control level while at the dose of 10−6M l-NMMA, AT1R protein was 171 ± 15% of the control level). Specific inhibition of nNOS, using antisense, caused an increase in AT1R expression while overexpression of nNOS, using adenoviral gene transfer (Ad.nNOS), caused an inhibition of AT1R expression in NG108 cells. Antisense nNOS transfection augmented the increase while Ad.nNOS infection blunted the increase in intracellular calcium concentration in response to ANG II treatment in NG108 cells. In addition, downregulation of AT1R mRNA as well as protein level in neuronal cell line in response to S-nitroso- N-acetyl pencillamine (SNAP) treatment was blocked by protein kinase G (PKG) inhibitor, while the peroxynitrite scavenger deforxamine had no effect. These results suggest that NO acts as an inhibitory regulator of AT1R expression and the activation of PKG is the required step in the regulation of AT1R gene expression via cGMP-dependent signaling pathway.Keywords
This publication has 55 references indexed in Scilit:
- Angiotensin-converting enzyme 2 overexpression improves central nitric oxide-mediated sympathetic outflow in chronic heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Gene Transfer of Neuronal Nitric Oxide Synthase to the Paraventricular Nucleus Reduces the Enhanced Glutamatergic Tone in Rats With Chronic Heart FailureHypertension, 2011
- Angiotensin-(1–7) increases neuronal potassium current via a nitric oxide-dependent mechanismAmerican Journal of Physiology-Cell Physiology, 2011
- Angiotensin II-induced upregulation of AT1 receptor expression: sequential activation of NF-κB and Elk-1 in neuronsAmerican Journal of Physiology-Cell Physiology, 2010
- Chronic AT1receptor blockade normalizes NMDA-mediated changes in renal sympathetic nerve activity and NR1expression within the PVN in rats with heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Enhanced angiotensin-mediated excitation of renal sympathetic nerve activity within the paraventricular nucleus of anesthetized rats with heart failureAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Superoxide Mediates Angiotensin II–Induced Influx of Extracellular Calcium in Neural CellsHypertension, 2005
- Nitric oxide regulates angiotensin II receptors in vascular smooth muscle cellsEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Angiotensin II exerts differential actions on renal nerve activity and heart rate.Hypertension, 1994
- Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells.Hypertension, 1991